541 related articles for article (PubMed ID: 22042871)
1. FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders.
Kiyota T; Ingraham KL; Jacobsen MT; Xiong H; Ikezu T
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1339-48. PubMed ID: 22042871
[TBL] [Abstract][Full Text] [Related]
2. AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice.
Kiyota T; Ingraham KL; Swan RJ; Jacobsen MT; Andrews SJ; Ikezu T
Gene Ther; 2012 Jul; 19(7):724-33. PubMed ID: 21918553
[TBL] [Abstract][Full Text] [Related]
3. Modulating adult neurogenesis affects synaptic plasticity and cognitive functions in mouse models of Alzheimer's disease.
Zhang X; Wei X; Mei Y; Wang D; Wang J; Zhang Y; Li X; Gu Y; Peng G; Sun B
Stem Cell Reports; 2021 Dec; 16(12):3005-3019. PubMed ID: 34861165
[TBL] [Abstract][Full Text] [Related]
4. Cerebral dopamine neurotrophic factor improves long-term memory in APP/PS1 transgenic mice modeling Alzheimer's disease as well as in wild-type mice.
Kemppainen S; Lindholm P; Galli E; Lahtinen HM; Koivisto H; Hämäläinen E; Saarma M; Tanila H
Behav Brain Res; 2015 Sep; 291():1-11. PubMed ID: 25975173
[TBL] [Abstract][Full Text] [Related]
5. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.
Zhang C; McNeil E; Dressler L; Siman R
Exp Neurol; 2007 Mar; 204(1):77-87. PubMed ID: 17070803
[TBL] [Abstract][Full Text] [Related]
6. Chronic pain accelerates cognitive impairment by reducing hippocampal neurogenesis may via CCL2/CCR2 signaling in APP/PS1 mice.
Chen L; Qin Q; Huang P; Cao F; Yin M; Xie Y; Wang W
Brain Res Bull; 2023 Dec; 205():110801. PubMed ID: 37931808
[TBL] [Abstract][Full Text] [Related]
7. Electroacupuncture decreases cognitive impairment and promotes neurogenesis in the APP/PS1 transgenic mice.
Li X; Guo F; Zhang Q; Huo T; Liu L; Wei H; Xiong L; Wang Q
BMC Complement Altern Med; 2014 Jan; 14():37. PubMed ID: 24447795
[TBL] [Abstract][Full Text] [Related]
8. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
9. AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease.
Kiyota T; Zhang G; Morrison CM; Bosch ME; Weir RA; Lu Y; Dong W; Gendelman HE
Mol Ther; 2015 Nov; 23(11):1712-1721. PubMed ID: 26227349
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer's disease.
Zeng Q; Zheng M; Zhang T; He G
Neuroscience; 2016 Feb; 314():64-74. PubMed ID: 26639620
[TBL] [Abstract][Full Text] [Related]
11. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.
Rolyan H; Scheffold A; Heinrich A; Begus-Nahrmann Y; Langkopf BH; Hölter SM; Vogt-Weisenhorn DM; Liss B; Wurst W; Lie DC; Thal DR; Biber K; Rudolph KL
Brain; 2011 Jul; 134(Pt 7):2044-56. PubMed ID: 21672962
[TBL] [Abstract][Full Text] [Related]
12. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease.
Kanninen K; Heikkinen R; Malm T; Rolova T; Kuhmonen S; Leinonen H; Ylä-Herttuala S; Tanila H; Levonen AL; Koistinaho M; Koistinaho J
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16505-10. PubMed ID: 19805328
[TBL] [Abstract][Full Text] [Related]
13. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.
Fol R; Braudeau J; Ludewig S; Abel T; Weyer SW; Roederer JP; Brod F; Audrain M; Bemelmans AP; Buchholz CJ; Korte M; Cartier N; Müller UC
Acta Neuropathol; 2016 Feb; 131(2):247-266. PubMed ID: 26538149
[TBL] [Abstract][Full Text] [Related]
14. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
[TBL] [Abstract][Full Text] [Related]
15. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
16. Early Impairments of Hippocampal Neurogenesis in 5xFAD Mouse Model of Alzheimer's Disease Are Associated with Altered Expression of SOXB Transcription Factors.
Zaletel I; Schwirtlich M; Perović M; Jovanović M; Stevanović M; Kanazir S; Puškaš N
J Alzheimers Dis; 2018; 65(3):963-976. PubMed ID: 30103323
[TBL] [Abstract][Full Text] [Related]
17. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
18. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
[TBL] [Abstract][Full Text] [Related]
19. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
Hamilton A; Holscher C
Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease.
Biscaro B; Lindvall O; Tesco G; Ekdahl CT; Nitsch RM
Neurodegener Dis; 2012; 9(4):187-98. PubMed ID: 22584394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
